Eskens FA - Search Results

1

Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

Mom CH, Verweij J, Oldenhuis CN, Gietema JA, Fox NL, Miceli R, Eskens FA, Loos WJ, de Vries EG, Sleijfer S. Mom CH, et al. Among authors: eskens fa. Clin Cancer Res. 2009 Sep 1;15(17):5584-90. doi: 10.1158/1078-0432.CCR-09-0996. Epub 2009 Aug 18. Clin Cancer Res. 2009. PMID: 19690193 Clinical Trial.

2

Phase II study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma.

van den Bent MJ, Pronk L, Sillevis Smitt PA, Vecht CJ, Eskens FA, Verweij J. van den Bent MJ, et al. Among authors: eskens fa. J Neurooncol. 1999 Aug;44(1):59-64. doi: 10.1023/a:1006201909435. J Neurooncol. 1999. PMID: 10582670 Clinical Trial.

3

Effect of food on the pharmacokinetics of oral MMI270B (CGS 27023A), a novel matrix metalloproteinase inhibitor.

Eskens FA, Levitt NC, Sparreboom A, Choi L, Mather R, Verweij J, Harris AL. Eskens FA, et al. Clin Cancer Res. 2000 Feb;6(2):431-3. Clin Cancer Res. 2000. PMID: 10690520 Clinical Trial.

4

Clinical studies in the development of new anticancer agents exhibiting growth inhibition in models: facing the challenge of a proper study design.

Eskens FA, Verweij J. Eskens FA, et al. Crit Rev Oncol Hematol. 2000 May;34(2):83-8. doi: 10.1016/s1040-8428(00)00055-x. Crit Rev Oncol Hematol. 2000. PMID: 10799834 Review.

5

Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.

Eskens FA, Greim GA, van Zuylen C, Wolff I, Denis LJ, Planting AS, Muskiet FA, Wanders J, Barbet NC, Choi L, Capdeville R, Verweij J, Hanauske AR, Bruntsch U. Eskens FA, et al. Clin Cancer Res. 2000 May;6(5):1736-43. Clin Cancer Res. 2000. PMID: 10815892 Clinical Trial.

6

Farnesyl transferase inhibitors: current developments and future perspectives.

Eskens FA, Stoter G, Verweij J. Eskens FA, et al. Cancer Treat Rev. 2000 Oct;26(5):319-32. doi: 10.1053/ctrv.2000.0187. Cancer Treat Rev. 2000. PMID: 11006134 Review.

7

Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors.

Eskens FA, Awada A, Cutler DL, de Jonge MJ, Luyten GP, Faber MN, Statkevich P, Sparreboom A, Verweij J, Hanauske AR, Piccart M; European Organization for Research and Treatment of Cancer Early Clinical Studies Group. Eskens FA, et al. J Clin Oncol. 2001 Feb 15;19(4):1167-75. doi: 10.1200/JCO.2001.19.4.1167. J Clin Oncol. 2001. PMID: 11181683 Clinical Trial.

8

Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer.

Levitt NC, Eskens FA, O'Byrne KJ, Propper DJ, Denis LJ, Owen SJ, Choi L, Foekens JA, Wilner S, Wood JM, Nakajima M, Talbot DC, Steward WP, Harris AL, Verweij J. Levitt NC, et al. Among authors: eskens fa. Clin Cancer Res. 2001 Jul;7(7):1912-22. Clin Cancer Res. 2001. PMID: 11448904 Clinical Trial.

9

Matrix metalloproteinase inhibitors: current developments and future perspectives.

Hoekstra R, Eskens FA, Verweij J. Hoekstra R, et al. Among authors: eskens fa. Oncologist. 2001;6(5):415-27. doi: 10.1634/theoncologist.6-5-415. Oncologist. 2001. PMID: 11675519 Free article. Review.

10

[Developments in chemotherapy; cytostatic agents with an increased specificity and other forms of administering cytotoxic antineoplastic agents].

Eskens FA, de Jonge MJ, Verweij J. Eskens FA, et al. Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2208-13. Ned Tijdschr Geneeskd. 2001. PMID: 11757242 Review. Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters